416 related articles for article (PubMed ID: 29289666)
1. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
2. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
[TBL] [Abstract][Full Text] [Related]
3. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.
Zhu W; Zhang Z; He S; Wong G; Banadyga L; Qiu X
Antiviral Res; 2018 Mar; 151():39-49. PubMed ID: 29369776
[TBL] [Abstract][Full Text] [Related]
5. Drug targets in infections with Ebola and Marburg viruses.
Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
[TBL] [Abstract][Full Text] [Related]
6. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model.
Smither SJ; Eastaugh LS; Steward JA; Nelson M; Lenk RP; Lever MS
Antiviral Res; 2014 Apr; 104():153-5. PubMed ID: 24462697
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus dynamics in mice treated with favipiravir.
Madelain V; Oestereich L; Graw F; Nguyen TH; de Lamballerie X; Mentré F; Günther S; Guedj J
Antiviral Res; 2015 Nov; 123():70-7. PubMed ID: 26343011
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
10. Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.
Madelain V; Guedj J; Mentré F; Nguyen TH; Jacquot F; Oestereich L; Kadota T; Yamada K; Taburet AM; de Lamballerie X; Raoul H
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27736754
[TBL] [Abstract][Full Text] [Related]
11. Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.
Madelain V; Baize S; Jacquot F; Reynard S; Fizet A; Barron S; Solas C; Lacarelle B; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X; Guedj J
Nat Commun; 2018 Oct; 9(1):4013. PubMed ID: 30275474
[TBL] [Abstract][Full Text] [Related]
12. T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques.
Espy N; Nagle E; Pfeffer B; Garcia K; Chitty AJ; Wiley M; Sanchez-Lockhart M; Bavari S; Warren T; Palacios G
Antiviral Res; 2019 Oct; 170():104529. PubMed ID: 31195019
[TBL] [Abstract][Full Text] [Related]
13. Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
Madelain V; Mentré F; Baize S; Anglaret X; Laouénan C; Oestereich L; Nguyen THT; Malvy D; Piorkowski G; Graw F; Günther S; Raoul H; de Lamballerie X; Guedj J
CPT Pharmacometrics Syst Pharmacol; 2020 May; 9(5):258-271. PubMed ID: 32198838
[TBL] [Abstract][Full Text] [Related]
14. Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates.
Reynard S; Gloaguen E; Baillet N; Madelain V; Guedj J; Raoul H; de Lamballerie X; Mullaert J; Baize S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009300. PubMed ID: 33780452
[TBL] [Abstract][Full Text] [Related]
15. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
[TBL] [Abstract][Full Text] [Related]
16. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
[TBL] [Abstract][Full Text] [Related]
18. Development of treatment strategies to combat Ebola and Marburg viruses.
Paragas J; Geisbert TW
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
[TBL] [Abstract][Full Text] [Related]
19. Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection.
Speranza E; Caballero I; Honko AN; Johnson JC; Bohannon JK; Evans DeWald L; Gerhardt DM; Sword J; Hensley LE; Bennett RS; Connor JH
mBio; 2020 Jun; 11(3):. PubMed ID: 32546624
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
